Astrana Net Working Capital from 2010 to 2026

ASTH Stock   22.41  0.41  1.86%   
Astrana Health's Net Working Capital is increasing with slightly volatile movements from year to year. Net Working Capital is predicted to flatten to about 229.6 M. For the period between 2010 and 2026, Astrana Health, Net Working Capital quarterly trend regression had mean deviation of  108,509,277 and range of 279.3 M. View All Fundamentals
 
Net Working Capital  
First Reported
2020-03-31
Previous Quarter
269.4 M
Current Value
253.7 M
Quarterly Volatility
34.5 M
 
Covid
 
Interest Hikes
Check Astrana Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Astrana Health's main balance sheet or income statement drivers, such as Interest Expense of 40 M, Other Operating Expenses of 2.3 B or Operating Income of 107.9 M, as well as many indicators such as Price To Sales Ratio of 1.18, Dividend Yield of 0.0029 or PTB Ratio of 2.45. Astrana financial statements analysis is a perfect complement when working with Astrana Health Valuation or Volatility modules.
  
Build AI portfolio with Astrana Stock
Check out the analysis of Astrana Health Correlation against competitors.
For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.

Latest Astrana Health's Net Working Capital Growth Pattern

Below is the plot of the Net Working Capital of Astrana Health over the last few years. It is Astrana Health's Net Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Astrana Health's overall financial position and show how it may be relating to other accounts over time.
Net Working Capital10 Years Trend
Slightly volatile
   Net Working Capital   
       Timeline  

Astrana Net Working Capital Regression Statistics

Arithmetic Mean144,403,611
Geometric Mean94,744,207
Coefficient Of Variation79.90
Mean Deviation108,509,277
Median100,843,145
Standard Deviation115,383,941
Sample Variance13313.5T
Range279.3M
R-Value0.89
Mean Square Error2909.2T
R-Squared0.80
Slope20,374,953
Total Sum of Squares213015.3T

Astrana Net Working Capital History

2026229.6 M
2025313.8 M
2024272.9 M
2023242.8 M
2022287.8 M
2021283.4 M
2020223.6 M

About Astrana Health Financial Statements

Investors use fundamental indicators, such as Astrana Health's Net Working Capital, to determine how well the company is positioned to perform in the future. Although Astrana Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Net Working Capital313.8 M229.6 M

Currently Active Assets on Macroaxis

When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock:
Check out the analysis of Astrana Health Correlation against competitors.
For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is there potential for Health Care Providers & Services market expansion? Will Astrana introduce new products? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.98)
Earnings Share
0.19
Revenue Per Share
59.463
Quarterly Revenue Growth
0.997
Return On Assets
0.0288
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Astrana Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Astrana Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Astrana Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.